AstraZeneca

Category

New England’s ActivMed Practices & Research Conducts Phase 3 COVID-19 Vaccine Trial in Portsmouth, New Hampshire

Residents in Massachusetts and New Hampshire can now participate in the pivotal Phase 3 trial testing the COVID-19 vaccine developed at Oxford University and now sponsored by AstraZeneca, known as AZD1222. Conducted by ActivMed Practices & Research LLC, the trial...

AstraZeneca selects Lonza as Contract Manufacturer for COVID-19 Long-Acting Antibody Combination Discovered by Vanderbilt Univ. Medical Center

AstraZeneca inked a deal just at the end of October with Swiss contract manufacturer Lonza to produce AZD7442, a combination of two long-acting antibodies (LAABs) for the potential prevention and treatment of COVID-19. The actual antibodies were discovered by...

Volunteer in the AstraZeneca AZD1222 Clinical Trial Dies in Brazil, However, Reports are Death Not Connected to Oxford Vaccine: Trial Apparently to Proceed

Shares of AstraZeneca’s stock declined as a volunteer participating in the Phase 3 clinical trial in Brazil died, reports Brazil’s food and drug regulator Anvisa. According to Reuters’ reports, the national coordinator of the study, the Federal University of Sao...

European Medicines Agency Initiates Rolling Review of AZD1222 While FDA Puts Trial on Hold for a Different Review

The European Medicines Agency (EMA) human medicines committee (CHMP) reports publicly the first ‘rolling review’ of a COVID-19 vaccine starting with AstraZeneca’s AZD1222 or the “Oxford” vaccine. This committee is investigating the first batch of data on the vaccine...

Pin It on Pinterest